168 related articles for article (PubMed ID: 38204987)
1. Integrative Analyses of Pyrimidine Salvage Pathway-Related Genes Revealing the Associations Between UPP1 and Tumor Microenvironment.
Li Y; Jiang M; Wei Y; He X; Li G; Lu C; Ge D
J Inflamm Res; 2024; 17():101-119. PubMed ID: 38204987
[TBL] [Abstract][Full Text] [Related]
2. UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment.
Li Y; Jiang M; Aye L; Luo L; Zhang Y; Xu F; Wei Y; Peng D; He X; Gu J; Yu X; Li G; Ge D; Lu C
Nat Commun; 2024 Feb; 15(1):1200. PubMed ID: 38331898
[TBL] [Abstract][Full Text] [Related]
3. UPP1 Promotes Lung Adenocarcinoma Progression through Epigenetic Regulation of Glycolysis.
Wang X; Wang Z; Huang R; Lu Z; Chen X; Huang D
Aging Dis; 2022 Oct; 13(5):1488-1503. PubMed ID: 36186123
[TBL] [Abstract][Full Text] [Related]
4. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
5. Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Guan Y; Bhandari A; Zhang X; Wang O
J Cell Mol Med; 2019 Nov; 23(11):7438-7448. PubMed ID: 31496029
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
7. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
[TBL] [Abstract][Full Text] [Related]
8. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
[TBL] [Abstract][Full Text] [Related]
10. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.
Zhang P; Dong S; Sun W; Zhong W; Xiong J; Gong X; Li J; Lin H; Zhuang Y
Front Mol Biosci; 2023; 10():1277530. PubMed ID: 37842637
[No Abstract] [Full Text] [Related]
11. Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and
Xu W; Zhang W; Zhao D; Wang Q; Zhang M; Li Q; Zhu W; Xu C
Front Immunol; 2023; 14():1242909. PubMed ID: 37753069
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma.
Wang T; Shi J; Li L; Zhou X; Zhang H; Zhang X; Wang Y; Liu L; Sheng L
Front Immunol; 2022; 13():840811. PubMed ID: 35515000
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
15. Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma.
Bian Y; Bi G; Shan G; Liang J; Yao G; Sui Q; Hu Z; Zhan C; Chen Z; Wang Q
Heliyon; 2023 Aug; 9(8):e18132. PubMed ID: 37529341
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.
Qin Y; Pan L; Qin T; Ruan H; Zhang Y; Zhang Y; Li J; Yang J; Li W
Front Immunol; 2022; 13():998266. PubMed ID: 36248785
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
19. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation.
Qin Y; Yang J; Liang C; Liu J; Deng Z; Yan B; Fu Y; Luo Y; Li X; Wei X; Li W
Front Immunol; 2022; 13():994828. PubMed ID: 36405728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
